Come up with a name for your new list and we'll add to it:
AnaBios raised a round of funding on June 01, 2013. Investors include
Tech Coast Angels.
AnaBios provides human-based drug response profiles in advance of clinical trials. AnaBios' Phase X (human tissue-based ex-vivo drug development studies) enables decision making concerning compound se…